Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04562636 · ClinicalTrials.gov registry record · NA
Evaluating a Messaging Campaign in the United States
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 1,244
- Enrollment target
NCT04562636: Completed NA study, sponsored by University of North Carolina, Chapel Hill.
NCT04562636 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 1,244 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (11% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04562636, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,244 participants
- Enrollment target
Study Summary
Purpose: To evaluate reactions to and opinions of a messaging campaign. Participants: Participants will be recruited through Prime Panels and will be US-based adults (18 years old and older) who consumed red meat in the past 30 days. Procedures (methods): After completing a screening question about meat consumption, participants will review a consent form. If they select to participate in the study, participants will be randomly assigned to view control messages, red meat-related environment messages, or red meat-related health messages. They will be asked a series of questions about these messages. Participants will also be asked about grocery shopping preferences and standard demographics questions.
Primary Outcome
Perceived effectiveness of the messages will be measured during the message using 4 items adapted from Baig et al. (2018): concern, unpleasantness, and discouragement. The averaged responses on the 4 items will be used to create a PME score. All 4 items are measured using a a 1 to 5 likert scale, with higher scores representing a higher amount of the construct. Questions: How much do these messages... * make you concerned about the health effects of eating red meat? * make you concerned about
Interventions
- OTHER Environmental message
- OTHER Health message
- OTHER Neutral Message
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,244 participants |
| Start Date | 2020-09-29 |
| Est. Completion | 2020-10-01 |
| Phase | NA |
What the finished NCT04562636 record still lists
NCT04562636 is an interventional study that assigns participants to a tested intervention. Its 1,244 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (11% lower).
The record links to 0 conditions, and to 3 interventions - of which Environmental message is the first listed.
NCT04562636 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04562636 about?
NCT04562636 is a clinical study titled "Evaluating a Messaging Campaign in the United States". Purpose: To evaluate reactions to and opinions of a messaging campaign. Participants: Participants will be recruited through Prime Panels and will be US-based adults (18 years old and older) who consumed red meat in the past 30 days. Procedures (methods): After completing a screening question abou...
What is the current status of trial NCT04562636?
This trial is currently completed. It is a NA study. The enrollment target is 1,244 participants. The study started on 2020-09-29. Estimated completion is 2020-10-01.
What interventions are being tested in trial NCT04562636?
The interventions under investigation include: Environmental message (OTHER), Health message (OTHER), Neutral Message (OTHER).
Who is sponsoring clinical trial NCT04562636?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04562636's enrollment target sits among peer trials
1,244 82nd of 2000 higher than 1,919 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06368245 · 1,244 participants
Durability of Suppl. Rod Constructs-SuppleMentAry Rod Technique for Long-segment Posterior Instrumented Spinal Fusions
- NCT02743858 · 1,250 participants
Lymphedema Surveillance Study
- NCT04670874 · 1,250 participants
Quality of Life in Cutaneous Lymphoma Patients Using the Skindex29
- NCT04807868 · 1,250 participants
AdventHealth Research Institute Non-Alcoholic Fatty Liver Disease Biobank and Registry (AVAIL)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI